ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE) | Finanzwire

Basculer en Français

11103	Companies
244258	Keywords
172360	Articles
131631	Press releases

Headlines Articles Press releases ORPHAN SYNERGY EUROPE-PHARMA

Home
Companies
ORPHAN SYNERGY EUROPE-PHARMA

BRIEF

published on 09/23/2026 at 07:35, 7 days 16 hours ago

Results of Combi-TED presented by OSE Immunotherapeutics

Lung Cancer OSE Immunotherapeutics Tedopi® Phase 2 Combi-TED ESMO Congress 2026
BRIEF

published on 09/23/2026 at 07:35, 7 days 16 hours ago

Topline Results of Tedopi® in Lung Cancer to be Presented at ESMO 2026

Clinical Study NSCLC Phase 2 Trial Tedopi® ESMO 2026
PRESS RELEASE

published on 09/23/2026 at 07:30, 7 days 16 hours ago

OSE Immunotherapeutics Announces Presentation of Combi-TED Phase 2 Topline Results of Tedopi® in Non-Small Cell Lung Cancer at the ESMO 2026 Meeting
OSE Immunotherapeutics presents Combi-TED Phase 2 Topline Results of Tedopi® in Non-Small Cell Lung Cancer at ESMO 2026 Meeting. The trial evaluates Tedopi® in second-line treatment for metastatic NSCLC

OSE Immunotherapeutics Non-Small Cell Lung Cancer Tedopi® ESMO 2026 Combi-TED
BRIEF

published on 08/28/2026 at 07:35, 1 month 3 days ago

OSE Immunotherapeutics: Webcast on Lusvertikimab with Experts

Webcast Inflammatory Diseases OSE Immunotherapeutics Medical Experts Lusvertikimab
BRIEF

published on 08/28/2026 at 07:35, 1 month 3 days ago

OSE Immunotherapeutics to Host Webcast on Lusvertikimab for Inflammatory Bowel Diseases

Clinical Trials Inflammatory Bowel Diseases OSE Immunotherapeutics Lusvertikimab Webcast Event
PRESS RELEASE

published on 08/28/2026 at 07:30, 1 month 3 days ago

OSE Immunotherapeutics to host a KOL webcast dedicated to lusvertikimab on September 2, 2026
OSE Immunotherapeutics to host KOL webcast on lusvertikimab, discussing IL-7R biology, CoTiKis trial results, and future plans on September 2, 2026

Inflammatory Bowel Diseases OSE Immunotherapeutics Lusvertikimab KOL Webcast IL-7R Biology
BRIEF

published on 06/03/2026 at 20:34, 3 months 27 days ago

OSE Immunotherapeutics General Assembly: access to preparatory documents

Shareholders Paris General Assembly Preparatory Documents OSE Immunotherapeutics
BRIEF

published on 06/03/2026 at 20:34, 3 months 27 days ago

OSE Immunotherapeutics to Hold Annual General Meeting on June 24, 2026

Annual General Meeting Shareholder Information OSE Immunotherapeutics Webcast Access Paris Event
PRESS RELEASE

published on 06/03/2026 at 20:29, 3 months 27 days ago

Annual General Meeting on June 24, 2026 Procedures for obtaining preparatory documents for the General Meeting
OSE Immunotherapeutics SA announces Annual General Meeting on June 24, 2026, with procedures for obtaining preparatory documents. Meeting details and documents available on company website

Annual General Meeting Shareholders French Commercial Code Preparatory Documents OSE Immunotherapeutics
BRIEF

published on 06/03/2026 at 20:24, 3 months 27 days ago

OSE Immunotherapeutics: Publication of 2025 Financial Results

Universal Registration Document OSE Immunotherapeutics Funding Strategy 2025 Financial Results IRIS Funding

1 2 ... 8

Accesswire

Published on 09/30/2026 at 23:30, 34 minutes ago

Early Warning News Release Issued with Respect to the Acquisition of Securities of Cypher Metaverse Inc.
Published on 09/30/2026 at 20:35, 3 hours 29 minutes ago

Fairplay Ventures Inc. Enters Into Definitive Agreement to Complete Qualifying Transaction With Ampere Metals Pty. Limited
Published on 09/30/2026 at 15:50, 8 hours 14 minutes ago

Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans
Published on 09/30/2026 at 14:37, 9 hours 27 minutes ago

NuRAN Leverages Starlink Backhaul to Drive Higher Revenue Per Rural Site
Published on 09/30/2026 at 14:31, 9 hours 33 minutes ago

First Breach Expands Ammunition Manufacturing Operations to Seven Days a Week

View all ACCESSWIRE

EQS Group

Published on 09/30/2026 at 23:23, 41 minutes ago

LM PAY S.A. publishes audited FY 2025 results: EBIT reaches PLN 12.4 million and exceeds preliminary result and guidance
Published on 09/30/2026 at 22:34, 1 hour 30 minutes ago

The Change of Date of the Annual Report 2025 Publication
Published on 09/30/2026 at 22:05, 1 hour 59 minutes ago

ADS-TEC Energy Reports First Half 2026 Results; Advances Gigawatt-Scale SKM Storage Project and Strengthens its Position to Scale Own & Operate Model
Published on 09/30/2026 at 22:05, 1 hour 59 minutes ago

Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
Published on 09/30/2026 at 20:50, 3 hours 14 minutes ago

EQS-Adhoc: Avemio AG: Adverse Audit Opinion on 2025 Consolidated Financial Statements and Group Management Report – 2025 Annual Report Published

Les Echos

Published on 09/30/2026 at 18:44, 5 hours 19 minutes ago

Broadcast of the 5th edition of “On the way up”
Published on 09/30/2026 at 18:15, 5 hours 49 minutes ago

The Belgian State and ENGIE Group have agreed to extend the target date for concluding the Heads of Terms until 4 november 2026
Published on 09/30/2026 at 18:00, 6 hours 4 minutes ago

Thales announces the distribution of an interim dividend
Published on 09/30/2026 at 18:00, 6 hours 4 minutes ago

Cie du Bois Sauvage : Compagnie du Bois Sauvage increases its stake in Eaglestone to support its long-term development (Inside information)
Published on 09/30/2026 at 12:00, 12 hours 4 minutes ago

Capital increase through exercise of subscription rights

View all LES ECHOS COMFI WIRE